Stephen Kanes - Net Worth and Insider Trading

Stephen Kanes Net Worth

The estimated net worth of Stephen Kanes is at least $11,198 dollars as of 2024-05-12. Stephen Kanes is the Chief Medical Officer of Sage Therapeutics Inc and owns about 941 shares of Sage Therapeutics Inc (SAGE) stock worth over $11,198. Details can be seen in Stephen Kanes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen Kanes has not made any transactions after 2019-02-08 and currently still holds the listed stock(s).

Transaction Summary of Stephen Kanes

To

Stephen Kanes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Kanes owns 1 companies in total, including Sage Therapeutics Inc (SAGE) .

Click here to see the complete history of Stephen Kanes’s form 4 insider trades.

Insider Ownership Summary of Stephen Kanes

Ticker Comapny Transaction Date Type of Owner
SAGE Sage Therapeutics Inc 2019-02-08 Chief Medical Officer

Stephen Kanes Latest Holdings Summary

Stephen Kanes currently owns a total of 1 stock. Stephen Kanes owns 941 shares of Sage Therapeutics Inc (SAGE) as of February 8, 2019, with a value of $11,198.

Latest Holdings of Stephen Kanes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SAGE Sage Therapeutics Inc 2019-02-08 941 11.90 11,198

Holding Weightings of Stephen Kanes


Stephen Kanes Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Kanes has made a total of 0 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years. The most-recent trade in Sage Therapeutics Inc is the sale of 22,948 shares on February 8, 2019, which brought Stephen Kanes around $3 Million.

Insider Trading History of Stephen Kanes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Kanes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen Kanes Ownership Network

Ownership Network List of Stephen Kanes

No Data

Ownership Network Relation of Stephen Kanes


Stephen Kanes Owned Company Details

What does Sage Therapeutics Inc do?

Who are the key executives at Sage Therapeutics Inc?

Stephen Kanes is the Chief Medical Officer of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .

Sage Therapeutics Inc (SAGE) Insider Trades Summary

Over the past 18 months, Stephen Kanes made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett , and a net sale of 11,643 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,643 shares of Sage Therapeutics Inc (SAGE) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 8,643 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sage Therapeutics Inc Insider Transactions

No Available Data

Stephen Kanes Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Kanes. You might contact Stephen Kanes via mailing address: 215 First Street, Cambridge Ma 02142.

Discussions on Stephen Kanes

No discussions yet.